Establishment and Investigation of a Multiple Gene Expression Signature to Predict Long-Term Survival in Pancreatic Cancer

Figure 5

The five-gene signature-based risk score in the prognosis of survival in the training cohort. (a) Risk score distribution of the final five-gene expression signature in high- and low-risk groups; (b) the expression profiles of the five-gene signatures from low- to high-risk score; (c) the vital survival status of patients in the high- and low-risk cohorts; (d) distribution of mortality rate in high- and low-risk score groups. (e) Kaplan-Meier analysis with log-rank test for overall survival of the PC patients in the high- and low-risk score groups; (f) Kaplan-Meier analysis with log-rank test for disease-free survival of the PC patients in the high- and low-risk score groups.

(a)

(b)

(c)

(d)

(e)

(f)